Dachaigh › Lymphoma Burkitt › Maryland › Baltimore
Sgrùdaidhean clionaigeach Lymphoma Burkitt ann an Baltimore, MD
Tha 8 sgrùdaidhean airson Lymphoma Burkitt a’ lorg phàirtichean aig làraichean ann agus timcheall air Baltimore (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
A’ fastadhÌre 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A’ fastadhÌre 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
A’ fastadhÌre 3
- Johns Hopkins Asthma & Allergy Center, Baltimore
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 1
- University of Maryland, Baltimore
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A’ fastadhÌre 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
A’ fastadhÌre 1
- University of Maryland, Baltimore
Sgrùdaidhean Lymphoma Burkitt ann am bailtean eile
- Houston, TX21 sgrùdaidhean
- Philadelphia, PA16 sgrùdaidhean
- Milwaukee, WI16 sgrùdaidhean
- Chicago, IL15 sgrùdaidhean
- Cincinnati, OH13 sgrùdaidhean
- New York City, NY13 sgrùdaidhean
- Atlanta, GA12 sgrùdaidhean
- Aurora, CO11 sgrùdadh
- Seattle, WA11 sgrùdadh
- Durham, NC10 sgrùdaidhean
- Boston, MA10 sgrùdaidhean
- Kansas City, MO10 sgrùdaidhean
Sgrùdaidhean eile ann an Baltimore
- Aillse Sgamhain Neo-chealla-beag60 sgrùdaidhean
- Aillse a' bhroilleach47 sgrùdaidhean
- Aillse Prostata43 sgrùdaidhean
- Ailseachadh nan Sgamhan40 sgrùdaidhean
- Aillse (gach seòrsa)37 sgrùdaidhean
- Cancer Pancreatic31 sgrùdaidhean
- Aillse colorectal31 sgrùdaidhean
- Ailse metastatach28 sgrùdaidhean
- Obesity26 sgrùdaidhean
- Aillse sa bhlaire24 sgrùdaidhean
- Fàilligeadh a' Chridhe24 sgrùdaidhean
- Cancer Ovarian22 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.